| Literature DB >> 33864704 |
Preeti Khurana1,2, Nikola Kolundzic1,2, Carsten Flohr3, Dusko Ilic1,2.
Abstract
To effectively study the skin and its pathology, various platforms have been used to date, with in vitro 3D skin models being considered the future gold standard. These models have generally been engineered from primary cell lines. However, their short life span leading to the use of various donors, imposes issues with genetic variation. Human pluripotent stem cell (hPSC)-technology holds great prospects as an alternative to the use of primary cell lines to study the pathophysiology of human skin diseases. This is due to their potential to generate an unlimited number of genetically identical skin models that closely mimic the complexity of in vivo human skin. During the past decade, researchers have therefore started to use human embryonic and induced pluripotent stem cells (hESC/iPSC) to derive skin resident-like cells and components. These have subsequently been used to engineer hPSC-derived 3D skin models. In this review, we focus on the advantages, recent developments, and future perspectives in using hPSCs as an alternative cell source for modelling human skin diseases in vitro.Entities:
Keywords: 3D skin; differentiation; human model; keratinocytes; stem cells
Mesh:
Year: 2021 PMID: 33864704 DOI: 10.1111/exd.14358
Source DB: PubMed Journal: Exp Dermatol ISSN: 0906-6705 Impact factor: 3.960